These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25586556)

  • 1. PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines.
    Yoon YS; Kim SY; Kim MJ; Lim JH; Cho MS; Kang JL
    Mucosal Immunol; 2015 Sep; 8(5):1031-46. PubMed ID: 25586556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A STAT6 Inhibitor AS1517499 Reduces Preventive Effects of Apoptotic Cell Instillation on Bleomycin-Induced Lung Fibrosis by Suppressing PPARγ.
    Kim MJ; Lee YJ; Yoon YS; Lim JH; Park EM; Chong YH; Kang JL
    Cell Physiol Biochem; 2018; 45(5):1863-1877. PubMed ID: 29510393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction.
    Lee YJ; Moon C; Lee SH; Park HJ; Seoh JY; Cho MS; Kang JL
    Eur Respir J; 2012 Aug; 40(2):424-35. PubMed ID: 22441736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PPARγ in carbon nanotube-elicited granulomatous lung inflammation.
    Huizar I; Malur A; Patel J; McPeek M; Dobbs L; Wingard C; Barna BP; Thomassen MJ
    Respir Res; 2013 Jan; 14(1):7. PubMed ID: 23343389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated induction of cyclooxygenase-2/prostaglandin E2 and hepatocyte growth factor by apoptotic cells prevents lung fibrosis.
    Yoon YS; Lee YJ; Choi JY; Cho MS; Kang JL
    J Leukoc Biol; 2013 Nov; 94(5):1037-49. PubMed ID: 23922381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model.
    Malur A; Mohan A; Barrington RA; Leffler N; Malur A; Muller-Borer B; Murray G; Kew K; Zhou C; Russell J; Jones JL; Wingard CJ; Barna BP; Thomassen MJ
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):198-208. PubMed ID: 30741559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone, a peroxisome proliferator-activated receptor gamma ligand, suppresses bleomycin-induced acute lung injury and fibrosis.
    Aoki Y; Maeno T; Aoyagi K; Ueno M; Aoki F; Aoki N; Nakagawa J; Sando Y; Shimizu Y; Suga T; Arai M; Kurabayashi M
    Respiration; 2009; 77(3):311-9. PubMed ID: 18974632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective effect of intervention with cannabinoid type-2 receptor agonist JWH133 on pulmonary fibrosis in mice].
    Wu X; Yang WT; Cheng YJ; Pan L; Zhang YQ; Zhu HL; Zhang ML
    Zhonghua Nei Ke Za Zhi; 2023 Jul; 62(7):841-849. PubMed ID: 37394854
    [No Abstract]   [Full Text] [Related]  

  • 11. The triterpenoid CDDO-Me inhibits bleomycin-induced lung inflammation and fibrosis.
    Kulkarni AA; Thatcher TH; Hsiao HM; Olsen KC; Kottmann RM; Morrissette J; Wright TW; Phipps RP; Sime PJ
    PLoS One; 2013; 8(5):e63798. PubMed ID: 23741300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
    Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARγ mediates the anti-pulmonary fibrosis effect of icaritin.
    Hua Q; Huang X; Xie W; Zhao F; Cheng H; Luo Z; Han J; Wang Z; Zeng Q; Lin M; Zhou T; Zhang J; Gu C; Liu W; Tang S
    Toxicol Lett; 2021 Oct; 350():81-90. PubMed ID: 34153405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic acid induces M2 macrophage polarization through peroxisome proliferator-activated receptor γ activation.
    Chang HY; Lee HN; Kim W; Surh YJ
    Life Sci; 2015 Jan; 120():39-47. PubMed ID: 25445227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.
    Jennewein C; Kuhn AM; Schmidt MV; Meilladec-Jullig V; von Knethen A; Gonzalez FJ; Brüne B
    J Immunol; 2008 Oct; 181(8):5646-52. PubMed ID: 18832723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: role of PPARγ receptors.
    Malekinejad H; Mehrabi M; Khoramjouy M; Rezaei-Golmisheh A
    Eur J Pharmacol; 2013 Nov; 720(1-3):294-302. PubMed ID: 24161914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Inflammatory, Antioxidant, and Antifibrotic Effects of Gingival-Derived MSCs on Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Wang X; Zhao S; Lai J; Guan W; Gao Y
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis.
    Huaux F; Liu T; McGarry B; Ullenbruch M; Xing Z; Phan SH
    J Immunol; 2003 Nov; 171(10):5470-81. PubMed ID: 14607953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wogonin prevents lipopolysaccharide-induced acute lung injury and inflammation in mice via peroxisome proliferator-activated receptor gamma-mediated attenuation of the nuclear factor-kappaB pathway.
    Yao J; Pan D; Zhao Y; Zhao L; Sun J; Wang Y; You QD; Xi T; Guo QL; Lu N
    Immunology; 2014 Oct; 143(2):241-57. PubMed ID: 24766487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell peroxisome proliferator-activated receptor γ reduces endotoxemic pulmonary inflammation and injury.
    Reddy AT; Lakshmi SP; Kleinhenz JM; Sutliff RL; Hart CM; Reddy RC
    J Immunol; 2012 Dec; 189(11):5411-20. PubMed ID: 23105142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.